Literature DB >> 2155250

Evidence of endocrine involvement early in the course of human immunodeficiency virus infection.

J A Merenich1, M T McDermott, A A Asp, S M Harrison, G S Kidd.   

Abstract

Adrenal, gonadal, and thyroid function were assessed in 40 asymptomatic subjects in whom infection with the human immunodeficiency virus (HIV) had recently been documented. None of the patients had historical or clinical evidence of endocrine dysfunction. Their mean serum hormone levels were also within the expected ranges, but several differences were noted compared to those of seronegative controls. Basal cortisol, basal aldosterone, and ACTH-stimulated cortisol were significantly lower in the HIV group. One subject (2.5%) had a subnormal cortisol response, and two (5%) had abnormal aldosterone responses to ACTH. PRA tended to be higher, and serum angiotensin-converting enzyme levels somewhat lower in the HIV group. Serum free testosterone was markedly elevated in the HIV patients and was associated with an exaggerated LH response to GnRH, but PRL, estradiol, and basal and peak GnRH-stimulated FSH did not differ between groups. Three subjects (8%) had subclinical hypothyroidism. Serum thyroid hormone levels were normal, but basal T3 was lower in the HIV group compared to control values. While of little immediate clinical importance, many subtle endocrine aberrations are evident very early in the course of HIV infection. These findings obtained in HIV-seropositive subjects without infections or tumors and who were not receiving medical therapy suggest an effect of HIV on each of the endocrine systems examined.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2155250     DOI: 10.1210/jcem-70-3-566

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  13 in total

1.  HIV gp120 inhibits the somatotropic axis: a possible GH-releasing hormone receptor mechanism for the pathogenesis of AIDS wasting.

Authors:  S E Mulroney; K J McDonnell; C B Pert; M R Ruff; Z Resch; W K Samson; M D Lumpkin
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

Review 2.  HIV and thyroid dysfunction.

Authors:  Alan A Parsa; Amrit Bhangoo
Journal:  Rev Endocr Metab Disord       Date:  2013-06       Impact factor: 6.514

Review 3.  Viruses in the mammalian male genital tract and their effects on the reproductive system.

Authors:  N Dejucq; B Jégou
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

Review 4.  Human immunodeficiency virus and highly active antiretroviral therapy-associated metabolic disorders and risk factors for cardiovascular disease.

Authors:  Erdembileg Anuurad; Alison Semrad; Lars Berglund
Journal:  Metab Syndr Relat Disord       Date:  2009-10       Impact factor: 1.894

Review 5.  Clinical use of sensitive assays for thyroid-stimulating hormone.

Authors:  P A Masters; R J Simons
Journal:  J Gen Intern Med       Date:  1996-02       Impact factor: 5.128

Review 6.  Systemic illness.

Authors:  Marta Bondanelli; Maria Chiara Zatelli; Maria Rosaria Ambrosio; Ettore C degli Uberti
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

7.  Alterations in the concentrations and binding properties of sex steroid binding protein and corticosteroid-binding globulin in HIV+patients.

Authors:  M E Martin; C Benassayag; C Amiel; P Canton; E A Nunez
Journal:  J Endocrinol Invest       Date:  1992-09       Impact factor: 4.256

8.  Thyroid hypofunction related with the progression of human immunodeficiency virus infection.

Authors:  A Olivieri; M Sorcini; P Battisti; C Fazzini; E Gilardi; Y Sun; E Medda; M Grandolfo; G Tossini; S Natili
Journal:  J Endocrinol Invest       Date:  1993-06       Impact factor: 4.256

Review 9.  Innate and adaptive immune responses in male and female reproductive tracts in homeostasis and following HIV infection.

Authors:  Philip V Nguyen; Jessica K Kafka; Victor H Ferreira; Kristy Roth; Charu Kaushic
Journal:  Cell Mol Immunol       Date:  2014-06-30       Impact factor: 11.530

10.  Antiprolactin autoantibodies are associated with hyperprolactinemic status in men infected with human immunodeficiency virus.

Authors:  Alfredo Leaños-Miranda; Iris Contreras-Hernández
Journal:  Endocrine       Date:  2002-11       Impact factor: 3.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.